Handelsavisen
prelaunch
Companies ›Healthcare ›6817.TWO
68
6817.TWO — TPEx Pharmaceuticals

Winston Medical Supply Co Ltd

$66,50
Open in Charts → Attach watcher ⌖
— —
TWD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,2B TWD
P/E
9,7x
EV / Rev
—
Div yield
10,14 %
Op margin
—
ROE
—
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

Winston Medical Supply Co Ltd operates in the pharmaceuticals industry, providing medical supplies and related products to healthcare providers and institutions.

Business. Winston Medical Supply Co Ltd (6817.TWO) is a healthcare company operating within the pharmaceuticals industry. The firm is primarily engaged in pharmaceuticals and medical research activities. It is listed on the Taiwan Premium Exchange (TPEx). Specific details regarding operating segments and geographic presence are not available.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryPharmaceuticals
ActivityPharmaceuticals & Medical Research
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation→
9,7x
P/E
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability
—
not yet wired
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 6817.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 6817.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Winston Medical Supply Co Ltd (6817.TWO) is a healthcare company operating within the pharmaceuticals industry. The firm is primarily engaged in pharmaceuticals and medical research activities. It is listed on the Taiwan Premium Exchange (TPEx). Specific details regarding operating segments and geographic presence are not available.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryPharmaceuticals
    ActivityPharmaceuticals & Medical Research
    AI synthesis
    GENERATED

    Winston Medical Supply Co Ltd has a market capitalization of TWD 1,136,328,900, with a market price of TWD 61.7 per share. The company has 18,417,000 basic and diluted shares outstanding, indicating no immediate dilution pressure from share issuance.

    Profitability and return metrics are not available for Winston Medical Supply Co Ltd due to the absence of balance-sheet inputs and relevant financial disclosures in the source documents. As a result, it is not possible to compare the company's performance against industry benchmarks or cohort medians.

    The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the extent of its international operations.

    Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Historical revenue data is also not available, making it difficult to assess the company's growth momentum or future potential.

    Risk factors include the inability to assess liquidity risk due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company is currently rated as having low dilution risk, with no immediate pressure from share issuance or capital-raising activities.

    Recent events, including filings and transcripts, are not disclosed in the available data. As a result, there is no information on recent corporate actions, management commentary, or strategic developments that could impact the company's performance.

    Key takeaways
    • Winston Medical Supply Co Ltd has a market capitalization of TWD 1,136,328,900 and a market price of TWD 61.7 per share.
    • The company has 18,417,000 basic and diluted shares outstanding, indicating no immediate dilution pressure.
    • Profitability and return metrics are not available due to the absence of balance-sheet inputs and relevant financial disclosures.
    • Revenue concentration and geographic exposure are not disclosed, limiting the ability to assess diversification.
    • Growth trajectory and historical revenue data are not available, making it difficult to assess future potential.
    • Liquidity risk cannot be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation FY

    Market price
    $66,50
    Market cap
    $1.14B
    Enterprise valueⓘ
    —
    P/Eⓘ
    9.7x
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    —
    Net cashⓘ
    —
    Current ratioⓘ
    —
    Debt / equityⓘ
    —
    ROAⓘ
    —
    ROEⓘ
    —
    Cash conversionⓘ
    —
    CapEx / revenueⓘ
    —
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Winston Medical Supply Co Ltd Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    6817.TWOCanonical
    TPEx · TWD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage